SMO-话题@MedSci

#SMO#

285篇内容 | 3653人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2024697, encodeId=20b7202469e47, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, objectTitle=CSMO 2014：周爱萍教授谈胃癌伴腹膜转移患者的治疗策略, objectType=article, longId=37526, objectId=4e143e5262e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e143e5262e, replyNumber=0, likeNumber=62, createdTime=2015-04-01, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e143e5262e, moduleTitle=CSMO 2014：周爱萍教授谈胃癌伴腹膜转移患者的治疗策略, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e143e5262e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2024728, encodeId=e1472024e2845, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, objectTitle=CSMO 2014 ：提高中央型肝癌治愈率的策略, objectType=article, longId=37823, objectId=37773e8234a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=37773e8234a, replyNumber=0, likeNumber=73, createdTime=2015-05-22, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=37773e8234a, moduleTitle=CSMO 2014 ：提高中央型肝癌治愈率的策略, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=37773e8234a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2024732, encodeId=5f3d2024e3287, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, objectTitle=CSMO 2014：鼻咽癌临床诊治现状和进展, objectType=article, longId=37827, objectId=6f5b3e82718, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f5b3e82718, replyNumber=0, likeNumber=77, createdTime=2014-11-17, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f5b3e82718, moduleTitle=CSMO 2014：鼻咽癌临床诊治现状和进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f5b3e82718)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2024748, encodeId=9caa2024e48dd, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, objectTitle=ESMO 2014：转移性乳腺癌基因组学和免疫学有何特征？, objectType=article, longId=40942, objectId=1d1840942f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1d1840942f8, replyNumber=0, likeNumber=110, createdTime=2015-04-20, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1d1840942f8, moduleTitle=ESMO 2014：转移性乳腺癌基因组学和免疫学有何特征？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1d1840942f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2024736, encodeId=5a1b2024e361d, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, objectTitle=CSMO 2014：徐瑞华教授谈晚期胃癌治疗进展, objectType=article, longId=38045, objectId=82183804510, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=82183804510, replyNumber=0, likeNumber=65, createdTime=2014-10-18, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=82183804510, moduleTitle=CSMO 2014：徐瑞华教授谈晚期胃癌治疗进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=82183804510)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2024707, encodeId=64082024e07ea, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, objectTitle=CSMO 2014：老年癌痛的药物治疗, objectType=article, longId=37603, objectId=71cb3e60385, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=71cb3e60385, replyNumber=0, likeNumber=112, createdTime=2015-04-19, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=71cb3e60385, moduleTitle=CSMO 2014：老年癌痛的药物治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=71cb3e60385)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2024710, encodeId=cfa22024e10a1, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, objectTitle=CSMO 2014 ：NK/T细胞淋巴瘤诊治新进展, objectType=article, longId=37606, objectId=e1023e60626, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e1023e60626, replyNumber=0, likeNumber=105, createdTime=2015-05-03, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e1023e60626, moduleTitle=CSMO 2014 ：NK/T细胞淋巴瘤诊治新进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e1023e60626)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2024684, encodeId=528d202468421, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, objectTitle=CSMO 2014 ：David Kerr教授谈结直肠癌氟尿嘧啶化疗的敏感性标志物, objectType=article, longId=37511, objectId=7ee73e51182, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7ee73e51182, replyNumber=0, likeNumber=67, createdTime=2015-06-02, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7ee73e51182, moduleTitle=CSMO 2014 ：David Kerr教授谈结直肠癌氟尿嘧啶化疗的敏感性标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7ee73e51182)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2024694, encodeId=5fce2024694a2, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, objectTitle=CSMO 2014：胃癌预后相关的生物标志物研究进展, objectType=article, longId=37522, objectId=fef43e52220, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fef43e52220, replyNumber=0, likeNumber=80, createdTime=2014-11-07, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fef43e52220, moduleTitle=CSMO 2014：胃癌预后相关的生物标志物研究进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fef43e52220)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2024715, encodeId=64952024e1587, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, objectTitle=CSMO 2014 ：S-1或为晚期非小细胞肺癌治疗新选择, objectType=article, longId=37611, objectId=e0c93e611ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e0c93e611ba, replyNumber=0, likeNumber=68, createdTime=2015-02-01, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e0c93e611ba, moduleTitle=CSMO 2014 ：S-1或为晚期非小细胞肺癌治疗新选择, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e0c93e611ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2024731, encodeId=afbf2024e31ac, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, objectTitle=CSMO 2014：肿瘤基因组学研究进展及临床转化应用, objectType=article, longId=37826, objectId=58f33e82652, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=58f33e82652, replyNumber=0, likeNumber=59, createdTime=2015-01-09, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=58f33e82652, moduleTitle=CSMO 2014：肿瘤基因组学研究进展及临床转化应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=58f33e82652)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2024699, encodeId=6a192024699d1, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, objectTitle=CSMO 2014：晚期非小细胞EGFR抑制剂的新进展与新思路, objectType=article, longId=37551, objectId=fad13e55151, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fad13e55151, replyNumber=0, likeNumber=69, createdTime=2014-08-20, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fad13e55151, moduleTitle=CSMO 2014：晚期非小细胞EGFR抑制剂的新进展与新思路, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fad13e55151)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2024698, encodeId=e01620246980a, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, objectTitle=CSMO 2014 ：胃癌靶向治疗的问题与发展, objectType=article, longId=37550, objectId=d1a83e550b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d1a83e550b1, replyNumber=0, likeNumber=63, createdTime=2014-09-20, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d1a83e550b1, moduleTitle=CSMO 2014 ：胃癌靶向治疗的问题与发展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d1a83e550b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2024704, encodeId=0f742024e042a, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, objectTitle=CSMO 2014 ：弥漫大B细胞淋巴瘤预后分子标志物研究进展, objectType=article, longId=37556, objectId=87f43e55666, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=87f43e55666, replyNumber=0, likeNumber=56, createdTime=2014-11-23, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=87f43e55666, moduleTitle=CSMO 2014 ：弥漫大B细胞淋巴瘤预后分子标志物研究进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=87f43e55666)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2024711, encodeId=32e62024e1159, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, objectTitle=CSMO 2014 ：晚期NSCLC个体化治疗时代化疗的新思路, objectType=article, longId=37607, objectId=4ae13e60780, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ae13e60780, replyNumber=0, likeNumber=76, createdTime=2015-01-17, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ae13e60780, moduleTitle=CSMO 2014 ：晚期NSCLC个体化治疗时代化疗的新思路, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4ae13e60780)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2024677, encodeId=8f4920246e78b, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, objectTitle=ESMO 2013：FIRE-3研究新数据解读, objectType=article, longId=26761, objectId=d7d526e61d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d7d526e61d5, replyNumber=0, likeNumber=81, createdTime=2014-08-03, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d7d526e61d5, moduleTitle=ESMO 2013：FIRE-3研究新数据解读, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d7d526e61d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2024678, encodeId=715220246e8ce, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, objectTitle=ESMO 2013:T-DM1可以使晚期HER2阳性乳腺癌二线治疗获益(TH3RESA研究）, objectType=article, longId=27180, objectId=0e472e180a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0e472e180a3, replyNumber=0, likeNumber=94, createdTime=2014-01-02, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e472e180a3, moduleTitle=ESMO 2013:T-DM1可以使晚期HER2阳性乳腺癌二线治疗获益(TH3RESA研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0e472e180a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2024680, encodeId=349c2024680a5, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, objectTitle=ESMO：新肿瘤患者骨健康临床实践指南, objectType=article, longId=34661, objectId=dd22346617d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dd22346617d, replyNumber=0, likeNumber=67, createdTime=2014-09-26, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dd22346617d, moduleTitle=ESMO：新肿瘤患者骨健康临床实践指南, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dd22346617d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2024679, encodeId=113920246e9b2, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, objectTitle=临床研究中SMO和CRO特点与前景, objectType=article, longId=27395, objectId=4a722e395ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4a722e395ce, replyNumber=0, likeNumber=75, createdTime=2014-04-15, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4a722e395ce, moduleTitle=临床研究中SMO和CRO特点与前景, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4a722e395ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2024675, encodeId=7fa820246e5d1, content=<a href='/topic/show?id=c27516459de' target=_blank style='color:#2F92EE;'>#SMO#</a>, objectTitle=ESMO年会：抗肾细胞癌疫苗研究取得进展, objectType=article, longId=10100, objectId=570a1010092, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=570a1010092, replyNumber=0, likeNumber=68, createdTime=2013-06-24, rootId=0, userName=liuhuangbo, userId=6779163, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=570a1010092, moduleTitle=ESMO年会：抗肾细胞癌疫苗研究取得进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=570a1010092)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

SMO

2020-05-29

liuhuangbo (审核中...)

前往app查看评论内容

#SMO#

CSMO 2014：周爱萍教授谈胃癌伴腹膜转移患者的治疗策略

2015-04-01

liuhuangbo (审核中...)

前往app查看评论内容

#SMO#

CSMO 2014 ：提高中央型肝癌治愈率的策略

2015-05-22

liuhuangbo (审核中...)

前往app查看评论内容

#SMO#

CSMO 2014：鼻咽癌临床诊治现状和进展

2014-11-17

liuhuangbo (审核中...)

前往app查看评论内容

#SMO#

ESMO 2014：转移性乳腺癌基因组学和免疫学有何特征？

2015-04-20

liuhuangbo (审核中...)

前往app查看评论内容

#SMO#

CSMO 2014：徐瑞华教授谈晚期胃癌治疗进展

2014-10-18

liuhuangbo (审核中...)

前往app查看评论内容

#SMO#

CSMO 2014：老年癌痛的药物治疗

2015-04-19

liuhuangbo (审核中...)

前往app查看评论内容

#SMO#

CSMO 2014 ：NK/T细胞淋巴瘤诊治新进展

2015-05-03

liuhuangbo (审核中...)

前往app查看评论内容

#SMO#

CSMO 2014 ：David Kerr教授谈结直肠癌氟尿嘧啶化疗的敏感性标志物

2015-06-02

liuhuangbo (审核中...)

前往app查看评论内容

#SMO#

CSMO 2014：胃癌预后相关的生物标志物研究进展

2014-11-07

liuhuangbo (审核中...)

前往app查看评论内容

#SMO#

CSMO 2014 ：S-1或为晚期非小细胞肺癌治疗新选择

2015-02-01

liuhuangbo (审核中...)

前往app查看评论内容

#SMO#

CSMO 2014：肿瘤基因组学研究进展及临床转化应用

2015-01-09

liuhuangbo (审核中...)

前往app查看评论内容

#SMO#

CSMO 2014：晚期非小细胞EGFR抑制剂的新进展与新思路

2014-08-20

liuhuangbo (审核中...)

前往app查看评论内容

#SMO#

CSMO 2014 ：胃癌靶向治疗的问题与发展

2014-09-20

liuhuangbo (审核中...)

前往app查看评论内容

#SMO#

CSMO 2014 ：弥漫大B细胞淋巴瘤预后分子标志物研究进展

2014-11-23

liuhuangbo (审核中...)

前往app查看评论内容

#SMO#

CSMO 2014 ：晚期NSCLC个体化治疗时代化疗的新思路

2015-01-17

liuhuangbo (审核中...)

前往app查看评论内容

#SMO#

ESMO 2013：FIRE-3研究新数据解读

2014-08-03

liuhuangbo (审核中...)

前往app查看评论内容

#SMO#

ESMO 2013:T-DM1可以使晚期HER2阳性乳腺癌二线治疗获益(TH3RESA研究）

2014-01-02

liuhuangbo (审核中...)

前往app查看评论内容

#SMO#

ESMO：新肿瘤患者骨健康临床实践指南

2014-09-26

liuhuangbo (审核中...)

前往app查看评论内容

#SMO#

临床研究中SMO和CRO特点与前景

2014-04-15

liuhuangbo (审核中...)

前往app查看评论内容

#SMO#

ESMO年会：抗肾细胞癌疫苗研究取得进展

2013-06-24

科室
- - 订阅+
  - 更多科室
工具
服务